Cabio Biotech (Wuhan) Co., Ltd. (688089.SS)
CNY 20.17
(-0.93%)
CNY 20.17
(-0.93%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 1.61 Billion CNY | 0.04% |
| 2022 | 1.61 Billion CNY | 11.21% |
| 2021 | 1.44 Billion CNY | 4.75% |
| 2020 | 1.38 Billion CNY | 6.55% |
| 2019 | 1.29 Billion CNY | 123.3% |
| 2018 | 581.19 Million CNY | 14.78% |
| 2017 | 506.36 Million CNY | 6.21% |
| 2016 | 476.77 Million CNY | 8.25% |
| 2015 | 440.42 Million CNY | -13.2% |
| 2014 | 507.41 Million CNY | 8.44% |
| 2013 | 467.92 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 1.61 Billion CNY | 0.36% |
| 2024 Q2 | 1.63 Billion CNY | 1.33% |
| 2024 Q3 | 1.66 Billion CNY | 1.57% |
| 2023 Q3 | 1.55 Billion CNY | -0.62% |
| 2023 Q1 | 1.59 Billion CNY | -1.16% |
| 2023 Q4 | 1.61 Billion CNY | 3.58% |
| 2023 FY | 1.61 Billion CNY | 0.04% |
| 2023 Q2 | 1.56 Billion CNY | -1.67% |
| 2022 Q3 | 1.54 Billion CNY | -1.43% |
| 2022 FY | 1.61 Billion CNY | 11.21% |
| 2022 Q1 | 1.47 Billion CNY | 1.5% |
| 2022 Q4 | 1.61 Billion CNY | 4.48% |
| 2022 Q2 | 1.56 Billion CNY | 6.39% |
| 2021 FY | 1.44 Billion CNY | 4.75% |
| 2021 Q4 | 1.44 Billion CNY | 2.77% |
| 2021 Q3 | 1.4 Billion CNY | 0.49% |
| 2021 Q2 | 1.4 Billion CNY | 0.4% |
| 2021 Q1 | 1.39 Billion CNY | 1.02% |
| 2020 Q3 | 1.34 Billion CNY | -1.51% |
| 2020 Q4 | 1.38 Billion CNY | 2.61% |
| 2020 Q1 | 1.31 Billion CNY | 1.69% |
| 2020 FY | 1.38 Billion CNY | 6.55% |
| 2020 Q2 | 1.36 Billion CNY | 3.67% |
| 2019 Q2 | 588.53 Million CNY | 0.0% |
| 2019 Q3 | 626.55 Million CNY | 6.46% |
| 2019 Q1 | - CNY | -100.0% |
| 2019 FY | 1.29 Billion CNY | 123.3% |
| 2019 Q4 | 1.29 Billion CNY | 107.14% |
| 2018 FY | 581.19 Million CNY | 14.78% |
| 2018 Q4 | 581.19 Million CNY | 0.0% |
| 2017 FY | 506.36 Million CNY | 6.21% |
| 2016 FY | 476.77 Million CNY | 8.25% |
| 2015 FY | 440.42 Million CNY | -13.2% |
| 2014 FY | 507.41 Million CNY | 8.44% |
| 2013 FY | 467.92 Million CNY | 0.0% |